Girard Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $11.4M | Sell |
10,818
-110
| -1% | -$116K | 1.08% | 21 |
|
|
2024
Q1 | $10.5M | Buy |
10,928
+86
| +0.8% | +$82.8K | 0.99% | 22 |
|
|
2023
Q4 | $9.52M | Buy |
10,842
+254
| +2% | +$223K | 0.97% | 28 |
|
|
2023
Q3 | $8.71M | Buy |
10,588
+142
| +1% | +$117K | 0.98% | 26 |
|
|
2023
Q2 | $7.51M | Sell |
10,446
-921
| -8% | -$662K | 0.79% | 30 |
|
|
2023
Q1 | $9.34M | Buy |
11,367
+2,828
| +33% | +$2.32M | 1.03% | 26 |
|
|
2022
Q4 | $6.16M | Buy |
8,539
+352
| +4% | +$254K | 0.7% | 33 |
|
|
2022
Q3 | $5.64M | Buy |
8,187
+2,024
| +33% | +$1.39M | 0.75% | 31 |
|
|
2022
Q2 | $3.64M | Sell |
6,163
-324
| -5% | -$192K | 0.46% | 59 |
|
|
2022
Q1 | $4.53M | Sell |
6,487
-189
| -3% | -$132K | 0.5% | 57 |
|
|
2021
Q4 | $4.22M | Buy |
6,676
+278
| +4% | +$176K | 0.46% | 69 |
|
|
2021
Q3 | $3.87M | Buy |
6,398
+66
| +1% | +$39.9K | 0.49% | 65 |
|
|
2021
Q2 | $3.54M | Buy |
6,332
+613
| +11% | +$342K | 0.45% | 70 |
|
|
2021
Q1 | $2.71M | Buy |
+5,719
| New | +$2.71M | 0.39% | 78 |
|
|
2018
Q4 | – | Sell |
-67
| Closed | -$27K | – | 684 |
|
|
2018
Q3 | $27K | Buy |
+67
| New | +$27K | ﹤0.01% | 553 |
|
|
2017
Q4 | – | Sell |
-467
| Closed | -$209K | – | 287 |
|
|
2017
Q3 | $209K | Sell |
467
-76
| -14% | -$34K | 0.04% | 241 |
|
|
2017
Q2 | $267K | Buy |
+543
| New | +$267K | 0.06% | 215 |
|